New patent covers autonomic nervous system assessment systems and methods
Autonomix Medical secured U.S. Patent No. 12,471,776 covering systems, kits and methods to assess autonomic nervous system activity.
The patent covers monitoring physiologic signals to evaluate sympathetic and parasympathetic function, supporting patient selection, procedural guidance and treatment feedback.
The company said the intellectual property expands its precision neuromodulation platform for peripheral nerve-targeted diagnosis and therapy.
AMIX•
